Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Nitroprusside × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Neoplasms 1 Hypertension 1

Interventions

Cyclophosphamide 2741 Cisplatin 2713 Carboplatin 2516 Radiotherapy 2326 Paclitaxel 2306 Gemcitabine 2174 pembrolizumab 1998 Docetaxel 1887 Bevacizumab 1826 Fluorouracil 1581 Capecitabine 1556 Oxaliplatin 1469 Dexamethasone 1366 Nivolumab 1292 Doxorubicin 1280 Rituximab 1262 Etoposide 1158 Magnetic Resonance Spectroscopy 1087 Irinotecan 1066 Leucovorin 1052 Cytarabine 987 fludarabine 912 Drug Therapy 912 Pemetrexed 899 Vincristine 816 Lenalidomide 800 Prednisone 798 Cetuximab 787 Filgrastim 783 Specimen Handling 781

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01125943 2013-01-10

Bevacizumab and Endothelium Dependent Vasodilation

Radboud University Medical Center

Phase NA Completed

Hypertension, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡